What You Should Know about Tymlos (Abaloparatide) for Osteoporosis

By Caila Brander, NWHN Policy Fellow There’s a new kid in town when it comes to osteoporosis drugs. Meet abaloparatide, brand name Tymlos, which was approved by the FDA on April 28, 2017. If you haven’t heard of it yet, you likely will soon, as manufacturer Radius Health is intent on marketing it until it’s … Continued

Letter to the Editor: Why Some Women are Afraid to Treat Osteoporosis

As a longtime Washington Post subscriber and women’s health advocate, I was disappointed to see “Why some women are afraid to treat osteoporosis” published on your website Tuesday. The author, in an attempt to emphasize the importance of appropriately treating osteoporosis, dismisses the very real and serious risks of bisphosphonate use. Bisphosphonates can be effective in … Continued

Standing Tall Against Falls & Fractures

There’s no denying that we live in a hyper-medicated society. Each week, it seems like the pharmaceutical industry develops a new drug or device — many of which are designed to treat newly invented conditions (see our article in the May/June issue on “binge eating disorder”)! We are inundated with advertisements for miracle drugs claiming … Continued

RX for Change: Choosing Wisely on Getting a Bone Density Test

Recommendations about bone density (BD) testing have shifted over the last few years — we are proud to say, more toward what the NWHN has recommended for over a decade! This article reviews the BD testing recommendations from the Choosing Wisely® (CW) campaign. This campaign grew from an American Board of Internal Medicine program called … Continued